Global Crizotinib API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

October 2026 | 129 pages | ID: G8510F8C8918EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Crizotinib API market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.

Crizotinib is an active pharmaceutical ingredient (API) used as a targeted therapy for cancers with ALK gene alterations,primarily non-small cell lung cancer (NSCLC).It works by inhibiting the ALK protein, which is involved in tumor growth.

This report is a detailed and comprehensive analysis for global Crizotinib API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Crizotinib API market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032

Global Crizotinib API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032

Global Crizotinib API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032

Global Crizotinib API market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2021-2026

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Crizotinib API
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace
This report profiles key players in the global Crizotinib API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MSN Laboratories, Greencross, Hetero Labs, Vama Lifecare, Croissance Biomed, Medicine House, Apothecon Pharmaceuticals, Tocris Bioscience, Selleck Chemicals, Cayman Chemical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Crizotinib API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Purity≥99%
  • Purity<99%

Market segment by Application

  • Online Sales
  • Offline Sales

Major players covered

  • MSN Laboratories
  • Greencross
  • Hetero Labs
  • Vama Lifecare
  • Croissance Biomed
  • Medicine House
  • Apothecon Pharmaceuticals
  • Tocris Bioscience
  • Selleck Chemicals
  • Cayman Chemical
  • Anant Pharmaceuticals
  • Adooq Bioscience
  • Focus Biomolecules
  • LC Laboratories
  • Hefei Home Sunshine Pharmaceutical Technology
  • Chongqing Huapont Shengchem Pharm
  • Xuzhou Wanbang Jinqiao Pharmaceutical

Market segment by region, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Crizotinib API product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Crizotinib API, with price, sales quantity, revenue, and global market share of Crizotinib API from 2021 to 2026.

Chapter 3, the Crizotinib API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Crizotinib API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Crizotinib API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Crizotinib API.

Chapter 14 and 15, to describe Crizotinib API sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Crizotinib API Consumption Value by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Purity≥99%
  1.3.3 Purity<99%
1.4 Market Analysis by Application
  1.4.1 Overview: Global Crizotinib API Consumption Value by Application: 2021 Versus 2025 Versus 2032
  1.4.2 Online Sales
  1.4.3 Offline Sales
1.5 Global Crizotinib API Market Size & Forecast
  1.5.1 Global Crizotinib API Consumption Value (2021 & 2025 & 2032)
  1.5.2 Global Crizotinib API Sales Quantity (2021-2032)
  1.5.3 Global Crizotinib API Average Price (2021-2032)

2 MANUFACTURERS PROFILES

2.1 MSN Laboratories
  2.1.1 MSN Laboratories Details
  2.1.2 MSN Laboratories Major Business
  2.1.3 MSN Laboratories Crizotinib API Product and Services
  2.1.4 MSN Laboratories Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 MSN Laboratories Recent Developments/Updates
2.2 Greencross
  2.2.1 Greencross Details
  2.2.2 Greencross Major Business
  2.2.3 Greencross Crizotinib API Product and Services
  2.2.4 Greencross Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 Greencross Recent Developments/Updates
2.3 Hetero Labs
  2.3.1 Hetero Labs Details
  2.3.2 Hetero Labs Major Business
  2.3.3 Hetero Labs Crizotinib API Product and Services
  2.3.4 Hetero Labs Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 Hetero Labs Recent Developments/Updates
2.4 Vama Lifecare
  2.4.1 Vama Lifecare Details
  2.4.2 Vama Lifecare Major Business
  2.4.3 Vama Lifecare Crizotinib API Product and Services
  2.4.4 Vama Lifecare Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 Vama Lifecare Recent Developments/Updates
2.5 Croissance Biomed
  2.5.1 Croissance Biomed Details
  2.5.2 Croissance Biomed Major Business
  2.5.3 Croissance Biomed Crizotinib API Product and Services
  2.5.4 Croissance Biomed Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 Croissance Biomed Recent Developments/Updates
2.6 Medicine House
  2.6.1 Medicine House Details
  2.6.2 Medicine House Major Business
  2.6.3 Medicine House Crizotinib API Product and Services
  2.6.4 Medicine House Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 Medicine House Recent Developments/Updates
2.7 Apothecon Pharmaceuticals
  2.7.1 Apothecon Pharmaceuticals Details
  2.7.2 Apothecon Pharmaceuticals Major Business
  2.7.3 Apothecon Pharmaceuticals Crizotinib API Product and Services
  2.7.4 Apothecon Pharmaceuticals Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 Apothecon Pharmaceuticals Recent Developments/Updates
2.8 Tocris Bioscience
  2.8.1 Tocris Bioscience Details
  2.8.2 Tocris Bioscience Major Business
  2.8.3 Tocris Bioscience Crizotinib API Product and Services
  2.8.4 Tocris Bioscience Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.8.5 Tocris Bioscience Recent Developments/Updates
2.9 Selleck Chemicals
  2.9.1 Selleck Chemicals Details
  2.9.2 Selleck Chemicals Major Business
  2.9.3 Selleck Chemicals Crizotinib API Product and Services
  2.9.4 Selleck Chemicals Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.9.5 Selleck Chemicals Recent Developments/Updates
2.10 Cayman Chemical
  2.10.1 Cayman Chemical Details
  2.10.2 Cayman Chemical Major Business
  2.10.3 Cayman Chemical Crizotinib API Product and Services
  2.10.4 Cayman Chemical Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.10.5 Cayman Chemical Recent Developments/Updates
2.11 Anant Pharmaceuticals
  2.11.1 Anant Pharmaceuticals Details
  2.11.2 Anant Pharmaceuticals Major Business
  2.11.3 Anant Pharmaceuticals Crizotinib API Product and Services
  2.11.4 Anant Pharmaceuticals Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.11.5 Anant Pharmaceuticals Recent Developments/Updates
2.12 Adooq Bioscience
  2.12.1 Adooq Bioscience Details
  2.12.2 Adooq Bioscience Major Business
  2.12.3 Adooq Bioscience Crizotinib API Product and Services
  2.12.4 Adooq Bioscience Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.12.5 Adooq Bioscience Recent Developments/Updates
2.13 Focus Biomolecules
  2.13.1 Focus Biomolecules Details
  2.13.2 Focus Biomolecules Major Business
  2.13.3 Focus Biomolecules Crizotinib API Product and Services
  2.13.4 Focus Biomolecules Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.13.5 Focus Biomolecules Recent Developments/Updates
2.14 LC Laboratories
  2.14.1 LC Laboratories Details
  2.14.2 LC Laboratories Major Business
  2.14.3 LC Laboratories Crizotinib API Product and Services
  2.14.4 LC Laboratories Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.14.5 LC Laboratories Recent Developments/Updates
2.15 Hefei Home Sunshine Pharmaceutical Technology
  2.15.1 Hefei Home Sunshine Pharmaceutical Technology Details
  2.15.2 Hefei Home Sunshine Pharmaceutical Technology Major Business
  2.15.3 Hefei Home Sunshine Pharmaceutical Technology Crizotinib API Product and Services
  2.15.4 Hefei Home Sunshine Pharmaceutical Technology Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.15.5 Hefei Home Sunshine Pharmaceutical Technology Recent Developments/Updates
2.16 Chongqing Huapont Shengchem Pharm
  2.16.1 Chongqing Huapont Shengchem Pharm Details
  2.16.2 Chongqing Huapont Shengchem Pharm Major Business
  2.16.3 Chongqing Huapont Shengchem Pharm Crizotinib API Product and Services
  2.16.4 Chongqing Huapont Shengchem Pharm Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.16.5 Chongqing Huapont Shengchem Pharm Recent Developments/Updates
2.17 Xuzhou Wanbang Jinqiao Pharmaceutical
  2.17.1 Xuzhou Wanbang Jinqiao Pharmaceutical Details
  2.17.2 Xuzhou Wanbang Jinqiao Pharmaceutical Major Business
  2.17.3 Xuzhou Wanbang Jinqiao Pharmaceutical Crizotinib API Product and Services
  2.17.4 Xuzhou Wanbang Jinqiao Pharmaceutical Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.17.5 Xuzhou Wanbang Jinqiao Pharmaceutical Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: CRIZOTINIB API BY MANUFACTURER

3.1 Global Crizotinib API Sales Quantity by Manufacturer (2021-2026)
3.2 Global Crizotinib API Revenue by Manufacturer (2021-2026)
3.3 Global Crizotinib API Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
  3.4.1 Producer Shipments of Crizotinib API by Manufacturer Revenue ($MM) and Market Share (%): 2025
  3.4.2 Top 3 Crizotinib API Manufacturer Market Share in 2025
  3.4.3 Top 6 Crizotinib API Manufacturer Market Share in 2025
3.5 Crizotinib API Market: Overall Company Footprint Analysis
  3.5.1 Crizotinib API Market: Region Footprint
  3.5.2 Crizotinib API Market: Company Product Type Footprint
  3.5.3 Crizotinib API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Crizotinib API Market Size by Region
  4.1.1 Global Crizotinib API Sales Quantity by Region (2021-2032)
  4.1.2 Global Crizotinib API Consumption Value by Region (2021-2032)
  4.1.3 Global Crizotinib API Average Price by Region (2021-2032)
4.2 North America Crizotinib API Consumption Value (2021-2032)
4.3 Europe Crizotinib API Consumption Value (2021-2032)
4.4 Asia-Pacific Crizotinib API Consumption Value (2021-2032)
4.5 South America Crizotinib API Consumption Value (2021-2032)
4.6 Middle East & Africa Crizotinib API Consumption Value (2021-2032)

5 MARKET SEGMENT BY TYPE

5.1 Global Crizotinib API Sales Quantity by Type (2021-2032)
5.2 Global Crizotinib API Consumption Value by Type (2021-2032)
5.3 Global Crizotinib API Average Price by Type (2021-2032)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Crizotinib API Sales Quantity by Application (2021-2032)
6.2 Global Crizotinib API Consumption Value by Application (2021-2032)
6.3 Global Crizotinib API Average Price by Application (2021-2032)

7 NORTH AMERICA

7.1 North America Crizotinib API Sales Quantity by Type (2021-2032)
7.2 North America Crizotinib API Sales Quantity by Application (2021-2032)
7.3 North America Crizotinib API Market Size by Country
  7.3.1 North America Crizotinib API Sales Quantity by Country (2021-2032)
  7.3.2 North America Crizotinib API Consumption Value by Country (2021-2032)
  7.3.3 United States Market Size and Forecast (2021-2032)
  7.3.4 Canada Market Size and Forecast (2021-2032)
  7.3.5 Mexico Market Size and Forecast (2021-2032)

8 EUROPE

8.1 Europe Crizotinib API Sales Quantity by Type (2021-2032)
8.2 Europe Crizotinib API Sales Quantity by Application (2021-2032)
8.3 Europe Crizotinib API Market Size by Country
  8.3.1 Europe Crizotinib API Sales Quantity by Country (2021-2032)
  8.3.2 Europe Crizotinib API Consumption Value by Country (2021-2032)
  8.3.3 Germany Market Size and Forecast (2021-2032)
  8.3.4 France Market Size and Forecast (2021-2032)
  8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  8.3.6 Russia Market Size and Forecast (2021-2032)
  8.3.7 Italy Market Size and Forecast (2021-2032)

9 ASIA-PACIFIC

9.1 Asia-Pacific Crizotinib API Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Crizotinib API Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Crizotinib API Market Size by Region
  9.3.1 Asia-Pacific Crizotinib API Sales Quantity by Region (2021-2032)
  9.3.2 Asia-Pacific Crizotinib API Consumption Value by Region (2021-2032)
  9.3.3 China Market Size and Forecast (2021-2032)
  9.3.4 Japan Market Size and Forecast (2021-2032)
  9.3.5 South Korea Market Size and Forecast (2021-2032)
  9.3.6 India Market Size and Forecast (2021-2032)
  9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  9.3.8 Australia Market Size and Forecast (2021-2032)

10 SOUTH AMERICA

10.1 South America Crizotinib API Sales Quantity by Type (2021-2032)
10.2 South America Crizotinib API Sales Quantity by Application (2021-2032)
10.3 South America Crizotinib API Market Size by Country
  10.3.1 South America Crizotinib API Sales Quantity by Country (2021-2032)
  10.3.2 South America Crizotinib API Consumption Value by Country (2021-2032)
  10.3.3 Brazil Market Size and Forecast (2021-2032)
  10.3.4 Argentina Market Size and Forecast (2021-2032)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Crizotinib API Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Crizotinib API Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Crizotinib API Market Size by Country
  11.3.1 Middle East & Africa Crizotinib API Sales Quantity by Country (2021-2032)
  11.3.2 Middle East & Africa Crizotinib API Consumption Value by Country (2021-2032)
  11.3.3 Turkey Market Size and Forecast (2021-2032)
  11.3.4 Egypt Market Size and Forecast (2021-2032)
  11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  11.3.6 South Africa Market Size and Forecast (2021-2032)

12 MARKET DYNAMICS

12.1 Crizotinib API Market Drivers
12.2 Crizotinib API Market Restraints
12.3 Crizotinib API Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Crizotinib API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Crizotinib API
13.3 Crizotinib API Production Process
13.4 Industry Value Chain Analysis

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Crizotinib API Typical Distributors
14.3 Crizotinib API Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES

Table 1. Global Crizotinib API Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Crizotinib API Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. MSN Laboratories Major Business
Table 5. MSN Laboratories Crizotinib API Product and Services
Table 6. MSN Laboratories Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. MSN Laboratories Recent Developments/Updates
Table 8. Greencross Basic Information, Manufacturing Base and Competitors
Table 9. Greencross Major Business
Table 10. Greencross Crizotinib API Product and Services
Table 11. Greencross Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Greencross Recent Developments/Updates
Table 13. Hetero Labs Basic Information, Manufacturing Base and Competitors
Table 14. Hetero Labs Major Business
Table 15. Hetero Labs Crizotinib API Product and Services
Table 16. Hetero Labs Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Hetero Labs Recent Developments/Updates
Table 18. Vama Lifecare Basic Information, Manufacturing Base and Competitors
Table 19. Vama Lifecare Major Business
Table 20. Vama Lifecare Crizotinib API Product and Services
Table 21. Vama Lifecare Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Vama Lifecare Recent Developments/Updates
Table 23. Croissance Biomed Basic Information, Manufacturing Base and Competitors
Table 24. Croissance Biomed Major Business
Table 25. Croissance Biomed Crizotinib API Product and Services
Table 26. Croissance Biomed Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Croissance Biomed Recent Developments/Updates
Table 28. Medicine House Basic Information, Manufacturing Base and Competitors
Table 29. Medicine House Major Business
Table 30. Medicine House Crizotinib API Product and Services
Table 31. Medicine House Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Medicine House Recent Developments/Updates
Table 33. Apothecon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Apothecon Pharmaceuticals Major Business
Table 35. Apothecon Pharmaceuticals Crizotinib API Product and Services
Table 36. Apothecon Pharmaceuticals Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Apothecon Pharmaceuticals Recent Developments/Updates
Table 38. Tocris Bioscience Basic Information, Manufacturing Base and Competitors
Table 39. Tocris Bioscience Major Business
Table 40. Tocris Bioscience Crizotinib API Product and Services
Table 41. Tocris Bioscience Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Tocris Bioscience Recent Developments/Updates
Table 43. Selleck Chemicals Basic Information, Manufacturing Base and Competitors
Table 44. Selleck Chemicals Major Business
Table 45. Selleck Chemicals Crizotinib API Product and Services
Table 46. Selleck Chemicals Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Selleck Chemicals Recent Developments/Updates
Table 48. Cayman Chemical Basic Information, Manufacturing Base and Competitors
Table 49. Cayman Chemical Major Business
Table 50. Cayman Chemical Crizotinib API Product and Services
Table 51. Cayman Chemical Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Cayman Chemical Recent Developments/Updates
Table 53. Anant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Anant Pharmaceuticals Major Business
Table 55. Anant Pharmaceuticals Crizotinib API Product and Services
Table 56. Anant Pharmaceuticals Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Anant Pharmaceuticals Recent Developments/Updates
Table 58. Adooq Bioscience Basic Information, Manufacturing Base and Competitors
Table 59. Adooq Bioscience Major Business
Table 60. Adooq Bioscience Crizotinib API Product and Services
Table 61. Adooq Bioscience Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Adooq Bioscience Recent Developments/Updates
Table 63. Focus Biomolecules Basic Information, Manufacturing Base and Competitors
Table 64. Focus Biomolecules Major Business
Table 65. Focus Biomolecules Crizotinib API Product and Services
Table 66. Focus Biomolecules Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. Focus Biomolecules Recent Developments/Updates
Table 68. LC Laboratories Basic Information, Manufacturing Base and Competitors
Table 69. LC Laboratories Major Business
Table 70. LC Laboratories Crizotinib API Product and Services
Table 71. LC Laboratories Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. LC Laboratories Recent Developments/Updates
Table 73. Hefei Home Sunshine Pharmaceutical Technology Basic Information, Manufacturing Base and Competitors
Table 74. Hefei Home Sunshine Pharmaceutical Technology Major Business
Table 75. Hefei Home Sunshine Pharmaceutical Technology Crizotinib API Product and Services
Table 76. Hefei Home Sunshine Pharmaceutical Technology Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Hefei Home Sunshine Pharmaceutical Technology Recent Developments/Updates
Table 78. Chongqing Huapont Shengchem Pharm Basic Information, Manufacturing Base and Competitors
Table 79. Chongqing Huapont Shengchem Pharm Major Business
Table 80. Chongqing Huapont Shengchem Pharm Crizotinib API Product and Services
Table 81. Chongqing Huapont Shengchem Pharm Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. Chongqing Huapont Shengchem Pharm Recent Developments/Updates
Table 83. Xuzhou Wanbang Jinqiao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 84. Xuzhou Wanbang Jinqiao Pharmaceutical Major Business
Table 85. Xuzhou Wanbang Jinqiao Pharmaceutical Crizotinib API Product and Services
Table 86. Xuzhou Wanbang Jinqiao Pharmaceutical Crizotinib API Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 87. Xuzhou Wanbang Jinqiao Pharmaceutical Recent Developments/Updates
Table 88. Global Crizotinib API Sales Quantity by Manufacturer (2021-2026) & (kg)
Table 89. Global Crizotinib API Revenue by Manufacturer (2021-2026) & (USD Million)
Table 90. Global Crizotinib API Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 91. Market Position of Manufacturers in Crizotinib API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 92. Head Office and Crizotinib API Production Site of Key Manufacturer
Table 93. Crizotinib API Market: Company Product Type Footprint
Table 94. Crizotinib API Market: Company Product Application Footprint
Table 95. Crizotinib API New Market Entrants and Barriers to Market Entry
Table 96. Crizotinib API Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Crizotinib API Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 98. Global Crizotinib API Sales Quantity by Region (2021-2026) & (kg)
Table 99. Global Crizotinib API Sales Quantity by Region (2027-2032) & (kg)
Table 100. Global Crizotinib API Consumption Value by Region (2021-2026) & (USD Million)
Table 101. Global Crizotinib API Consumption Value by Region (2027-2032) & (USD Million)
Table 102. Global Crizotinib API Average Price by Region (2021-2026) & (US$/kg)
Table 103. Global Crizotinib API Average Price by Region (2027-2032) & (US$/kg)
Table 104. Global Crizotinib API Sales Quantity by Type (2021-2026) & (kg)
Table 105. Global Crizotinib API Sales Quantity by Type (2027-2032) & (kg)
Table 106. Global Crizotinib API Consumption Value by Type (2021-2026) & (USD Million)
Table 107. Global Crizotinib API Consumption Value by Type (2027-2032) & (USD Million)
Table 108. Global Crizotinib API Average Price by Type (2021-2026) & (US$/kg)
Table 109. Global Crizotinib API Average Price by Type (2027-2032) & (US$/kg)
Table 110. Global Crizotinib API Sales Quantity by Application (2021-2026) & (kg)
Table 111. Global Crizotinib API Sales Quantity by Application (2027-2032) & (kg)
Table 112. Global Crizotinib API Consumption Value by Application (2021-2026) & (USD Million)
Table 113. Global Crizotinib API Consumption Value by Application (2027-2032) & (USD Million)
Table 114. Global Crizotinib API Average Price by Application (2021-2026) & (US$/kg)
Table 115. Global Crizotinib API Average Price by Application (2027-2032) & (US$/kg)
Table 116. North America Crizotinib API Sales Quantity by Type (2021-2026) & (kg)
Table 117. North America Crizotinib API Sales Quantity by Type (2027-2032) & (kg)
Table 118. North America Crizotinib API Sales Quantity by Application (2021-2026) & (kg)
Table 119. North America Crizotinib API Sales Quantity by Application (2027-2032) & (kg)
Table 120. North America Crizotinib API Sales Quantity by Country (2021-2026) & (kg)
Table 121. North America Crizotinib API Sales Quantity by Country (2027-2032) & (kg)
Table 122. North America Crizotinib API Consumption Value by Country (2021-2026) & (USD Million)
Table 123. North America Crizotinib API Consumption Value by Country (2027-2032) & (USD Million)
Table 124. Europe Crizotinib API Sales Quantity by Type (2021-2026) & (kg)
Table 125. Europe Crizotinib API Sales Quantity by Type (2027-2032) & (kg)
Table 126. Europe Crizotinib API Sales Quantity by Application (2021-2026) & (kg)
Table 127. Europe Crizotinib API Sales Quantity by Application (2027-2032) & (kg)
Table 128. Europe Crizotinib API Sales Quantity by Country (2021-2026) & (kg)
Table 129. Europe Crizotinib API Sales Quantity by Country (2027-2032) & (kg)
Table 130. Europe Crizotinib API Consumption Value by Country (2021-2026) & (USD Million)
Table 131. Europe Crizotinib API Consumption Value by Country (2027-2032) & (USD Million)
Table 132. Asia-Pacific Crizotinib API Sales Quantity by Type (2021-2026) & (kg)
Table 133. Asia-Pacific Crizotinib API Sales Quantity by Type (2027-2032) & (kg)
Table 134. Asia-Pacific Crizotinib API Sales Quantity by Application (2021-2026) & (kg)
Table 135. Asia-Pacific Crizotinib API Sales Quantity by Application (2027-2032) & (kg)
Table 136. Asia-Pacific Crizotinib API Sales Quantity by Region (2021-2026) & (kg)
Table 137. Asia-Pacific Crizotinib API Sales Quantity by Region (2027-2032) & (kg)
Table 138. Asia-Pacific Crizotinib API Consumption Value by Region (2021-2026) & (USD Million)
Table 139. Asia-Pacific Crizotinib API Consumption Value by Region (2027-2032) & (USD Million)
Table 140. South America Crizotinib API Sales Quantity by Type (2021-2026) & (kg)
Table 141. South America Crizotinib API Sales Quantity by Type (2027-2032) & (kg)
Table 142. South America Crizotinib API Sales Quantity by Application (2021-2026) & (kg)
Table 143. South America Crizotinib API Sales Quantity by Application (2027-2032) & (kg)
Table 144. South America Crizotinib API Sales Quantity by Country (2021-2026) & (kg)
Table 145. South America Crizotinib API Sales Quantity by Country (2027-2032) & (kg)
Table 146. South America Crizotinib API Consumption Value by Country (2021-2026) & (USD Million)
Table 147. South America Crizotinib API Consumption Value by Country (2027-2032) & (USD Million)
Table 148. Middle East & Africa Crizotinib API Sales Quantity by Type (2021-2026) & (kg)
Table 149. Middle East & Africa Crizotinib API Sales Quantity by Type (2027-2032) & (kg)
Table 150. Middle East & Africa Crizotinib API Sales Quantity by Application (2021-2026) & (kg)
Table 151. Middle East & Africa Crizotinib API Sales Quantity by Application (2027-2032) & (kg)
Table 152. Middle East & Africa Crizotinib API Sales Quantity by Country (2021-2026) & (kg)
Table 153. Middle East & Africa Crizotinib API Sales Quantity by Country (2027-2032) & (kg)
Table 154. Middle East & Africa Crizotinib API Consumption Value by Country (2021-2026) & (USD Million)
Table 155. Middle East & Africa Crizotinib API Consumption Value by Country (2027-2032) & (USD Million)
Table 156. Crizotinib API Raw Material
Table 157. Key Manufacturers of Crizotinib API Raw Materials
Table 158. Crizotinib API Typical Distributors
Table 159. Crizotinib API Typical Customers

LIST OF FIGURES

Figure 1. Crizotinib API Picture
Figure 2. Global Crizotinib API Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Crizotinib API Revenue Market Share by Type in 2025
Figure 4. Purity≥99% Examples
Figure 5. Purity<99% Examples
Figure 6. Global Crizotinib API Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Crizotinib API Revenue Market Share by Application in 2025
Figure 8. Online Sales Examples
Figure 9. Offline Sales Examples
Figure 10. Global Crizotinib API Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 11. Global Crizotinib API Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 12. Global Crizotinib API Sales Quantity (2021-2032) & (kg)
Figure 13. Global Crizotinib API Price (2021-2032) & (US$/kg)
Figure 14. Global Crizotinib API Sales Quantity Market Share by Manufacturer in 2025
Figure 15. Global Crizotinib API Revenue Market Share by Manufacturer in 2025
Figure 16. Producer Shipments of Crizotinib API by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 17. Top 3 Crizotinib API Manufacturer (Revenue) Market Share in 2025
Figure 18. Top 6 Crizotinib API Manufacturer (Revenue) Market Share in 2025
Figure 19. Global Crizotinib API Sales Quantity Market Share by Region (2021-2032)
Figure 20. Global Crizotinib API Consumption Value Market Share by Region (2021-2032)
Figure 21. North America Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 22. Europe Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 23. Asia-Pacific Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 24. South America Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 25. Middle East & Africa Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 26. Global Crizotinib API Sales Quantity Market Share by Type (2021-2032)
Figure 27. Global Crizotinib API Consumption Value Market Share by Type (2021-2032)
Figure 28. Global Crizotinib API Average Price by Type (2021-2032) & (US$/kg)
Figure 29. Global Crizotinib API Sales Quantity Market Share by Application (2021-2032)
Figure 30. Global Crizotinib API Revenue Market Share by Application (2021-2032)
Figure 31. Global Crizotinib API Average Price by Application (2021-2032) & (US$/kg)
Figure 32. North America Crizotinib API Sales Quantity Market Share by Type (2021-2032)
Figure 33. North America Crizotinib API Sales Quantity Market Share by Application (2021-2032)
Figure 34. North America Crizotinib API Sales Quantity Market Share by Country (2021-2032)
Figure 35. North America Crizotinib API Consumption Value Market Share by Country (2021-2032)
Figure 36. United States Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 37. Canada Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 38. Mexico Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 39. Europe Crizotinib API Sales Quantity Market Share by Type (2021-2032)
Figure 40. Europe Crizotinib API Sales Quantity Market Share by Application (2021-2032)
Figure 41. Europe Crizotinib API Sales Quantity Market Share by Country (2021-2032)
Figure 42. Europe Crizotinib API Consumption Value Market Share by Country (2021-2032)
Figure 43. Germany Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 44. France Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 45. United Kingdom Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 46. Russia Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 47. Italy Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 48. Asia-Pacific Crizotinib API Sales Quantity Market Share by Type (2021-2032)
Figure 49. Asia-Pacific Crizotinib API Sales Quantity Market Share by Application (2021-2032)
Figure 50. Asia-Pacific Crizotinib API Sales Quantity Market Share by Region (2021-2032)
Figure 51. Asia-Pacific Crizotinib API Consumption Value Market Share by Region (2021-2032)
Figure 52. China Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 53. Japan Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 54. South Korea Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 55. India Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 56. Southeast Asia Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 57. Australia Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 58. South America Crizotinib API Sales Quantity Market Share by Type (2021-2032)
Figure 59. South America Crizotinib API Sales Quantity Market Share by Application (2021-2032)
Figure 60. South America Crizotinib API Sales Quantity Market Share by Country (2021-2032)
Figure 61. South America Crizotinib API Consumption Value Market Share by Country (2021-2032)
Figure 62. Brazil Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 63. Argentina Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 64. Middle East & Africa Crizotinib API Sales Quantity Market Share by Type (2021-2032)
Figure 65. Middle East & Africa Crizotinib API Sales Quantity Market Share by Application (2021-2032)
Figure 66. Middle East & Africa Crizotinib API Sales Quantity Market Share by Country (2021-2032)
Figure 67. Middle East & Africa Crizotinib API Consumption Value Market Share by Country (2021-2032)
Figure 68. Turkey Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 69. Egypt Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 70. Saudi Arabia Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 71. South Africa Crizotinib API Consumption Value (2021-2032) & (USD Million)
Figure 72. Crizotinib API Market Drivers
Figure 73. Crizotinib API Market Restraints
Figure 74. Crizotinib API Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Crizotinib API in 2025
Figure 77. Manufacturing Process Analysis of Crizotinib API
Figure 78. Crizotinib API Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source